
The Groww IPO enters its second day of subscription today, 6 November 2025. By the end of the first day, the issue was subscribed 0.57 times overall, with the retail investors’ portion fully booked at 1.91 times. The bidding window will remain open until November 7, 2025.
The Groww IPO is a book-building issue of ₹6,632.3 crore, consisting of a fresh issue of ₹1,060 crore and an offer for sale of ₹5,572.30 crore. The price band is set between ₹95 and ₹100 per share.
The basis of allotment will be finalised by November 10, 2025, and the tentative listing date on NSE and BSE is November 12, 2025.
The book-running lead managers for the IPO are Kotak Mahindra Capital Company Limited, J.P. Morgan India Private Limited, Citigroup Global Markets India Private Limited, Axis Capital Limited, and Motilal Oswal Investment Advisors Limited, while MUFG Intime India Private Limited serves as the registrar for the issue.
[6-November-2025 10:33:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.10 |
|
Non-Institutional Investors |
1.00 |
|
Retail Individual Investors (RIIs) |
2.86 |
|
Total |
0.85 |
[4-November-2025 17:00:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.10 |
|
Non-Institutional Investors |
0.59 |
|
Retail Individual Investors (RIIs) |
1.91 |
|
Total |
0.57 |
The company will not receive any proceeds from the OFS (offer for sale) component; instead, they will be directly allocated to the selling shareholders.
The net proceeds from the fresh issue will be distributed towards
Groww is a leading D2C (direct-to-consumer) digital investment platform. Founded in 2016, it started as a mutual fund distribution platform (direct mutual funds) and quickly expanded into equities, IPOs, ETFs, digital gold, and derivatives (futures & options).
Groww is India’s largest and fastest-growing investment platform by active users on NSE as of June 30, 2025.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.
To read the Groww IPO disclaimer, please click here